↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

113 / 1,666 drugs found* Show info (disease name, etc.) on mouse-over.
 No.   DrugBank   薬物名(臨床試験情報から抽出)   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   Acetaminophen  8件: Acetaminophen; Acetaminophen tab 650mg; Acetaminophen/paracetamol; Acetaminophen tablets; Paracetamol (acetaminophen); Tramadol hydrochloride + acetaminophen; Oxycodone/acetaminophen; Tramadol /acetaminophen;   D00217   2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   13件:
3,
6,
13,
34,
35,
46,
49,
51,
70,
86,
231,
256,
271
 2   Acetate  81件: Acetate; Leuprorelin acetate; 40 mg glatiramer acetate; Betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 mg im once a day for four days; Flecainide acetate; Oxaloacetate (oaa); Ulipristal acetate; 11c-acetate; 20mg/0.5ml glatiramer acetate; Bazedoxifene acetate; Cyclophosphamide/glatiramer acetate; Dirucotide acetate; Experimental glatiramer acetate; Glatiramer acetate; Glatiramer acetate (db); Glatiramer acetate (ga); Glatiramer acetate (ga) 40 mg; Glatiramer acetate (ol); Glatiramer acetate 150mg enteric coated tablets; Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets; Glatiramer acetate 20 mg; Glatiramer acetate 20 mg, with mitoxantrone; Glatiramer acetate 20 mg/0.5 ml; Glatiramer acetate 40 mg; Glatiramer acetate injection with oral cetirizine hydrochloride; Glatiramer acetate with minocycline; Glatiramer acetate, (copaxone®); Glatiramer acetate, ifn-beta 1a (im), ifn-beta 1a (subcutaneous), and ifn-beta 1b; Glatiramer acetate, n-acetylcysteine; Human interferon beta-1a and glatiramer acetate; Nomegestrol acetate; Plovamer acetate; Prednisone acetate; Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol); Sodium-[o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate; Tocopherol acetate; Depot leuprolide acetate 3.75 mg; Caspofungin acetate; Desmopressin acetate; Lanreotide acetate; Abiraterone acetate; Gonadorelin acetate and triptorelin acetate; Leuprolide acetate (la); Leuprolide acetate 11.25 mg; Leuprolide acetate 3 month depot; Leuprolide acetate 30 mg; Leuprolide acetate 45 mg; Leuprolide acetate depot; Leuprorelin acetate 3.75mg injection; Luphere depot 3.75mg(leuprolide acetate 3.75mg); Lupron (leuprolide acetate); Megestrol acetate; Megestrol acetate tablet; Triptorelin acetate and gonadorelin acetate; Macimorelin acetate; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Cortisone acetate; Hydrocortisone sodium acetate; Sodium acetate; Tetracosactide acetate; 11c acetate; Dichloroacetate; Dichloroacetate sodium; Zuretinol acetate; Etiprednol dicloacetate; Delmitide acetate; L-lysyl-d-prolyl-l-threonine acetate; Sotrastaurin (inn) acetate; Cosyntropin acetate; Tetracosactide hexaacetate; Glatiramer acetate (copaxone®); Zinc acetate; Zinc acetate dihydrate; Tocopheryl acetate; Prednisolone acetate; Prednisone acetate tablets; Desmopressin acetate trihydrate; Phosphate and betamethasone acetate, 2 ml.; [n-trans-3-hexenoyl] human growth hormone releasing factor (1-44) acetate; Loestrin (norethindrone acetate and ethinyl estradiol); Zinc acetate (20mg/d);   -   -   -   40件:
1,
2,
6,
10,
13,
35,
40,
46,
49,
51,
60,
64,
70,
71,
73,
75,
76,
78,
81,
83,
85,
86,
88,
90,
96,
97,
113,
145,
156,
162,
171,
206,
222,
224,
225,
235,
265,
288,
298,
299
 3   Acetic acid C-11  0件:   -   -   -   3件:
13,
86,
88
 4   Acetylsalicylic acid  2件: Acetylsalicylic acid; Acetylsalicylic acid at 1st visit,;   D00109   2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   10件:
13,
22,
34,
46,
49,
51,
86,
113,
158,
231
 5   Activated charcoal  0件:   D03251   -   -   8件:
6,
13,
46,
85,
86,
96,
97,
298
 6   Ambrisentan  8件: Ambrisentan; Tadalafil and ambrisentan upfront combination therapy; Ambrisentan - high dose; Ambrisentan - low dose; Ambrisentan 5 mg film-coated tablets; Ambrisentan plus spironolactone; Bosentan, ambrisentan; Ambrisentan 5 mg;   D07077   1件: EDNRA   2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction   6件:
51,
84,
85,
86,
88,
211
 7   Anakinra  8件: Anakinra; Anakinra (kineret®); Anakinra (r-methuil-1ra); Anakinra and peg stnf-r1; Kineret® (anakinra); Response to anakinra associated with methotrexate; Anakinra / kineret; Kineret® or anakinra;   D02934   2件: IL1R1, IL1R2   2件: Cytokine-cytokine receptor interaction, Inflammatory mediator regulation of TRP channels   17件:
2,
13,
15,
19,
37,
41,
46,
49,
50,
56,
65,
84,
86,
106,
107,
266,
299
 8   Anastrozole  2件: Anastrozole; Arimidex (anastrozole);   D00960   1件: CYP19A1   1件: Steroid hormone biosynthesis   3件:
78,
86,
193
 9   Angiotensin II  2件: Angiotensin ii; Symptomatic treatment (converting enzyme inhibitor, angiotensin ii, anti-renin, aldosterone antagonist diuretic, beta blocker, calcium inhibitor, statin);   D00150
 D02014 
 2件: AGTR1, AGTR2   6件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction   7件:
17,
19,
46,
66,
86,
222,
224
 10   Apabetalone  1件: Apabetalone;   D11131   -   -   1件:
86
 11   Ascorbic acid  4件: Ascorbic acid; Ascorbic acid (vitamin c); Ascorbic acid vit c; 2l polyethylene glycol/ascorbic acid;   D00018   -   -   13件:
10,
13,
49,
62,
86,
96,
97,
192,
206,
211,
212,
254,
284
 12   Aviptadil  2件: Aviptadil; Aviptadil, 66 microgram/ml;   -   -   -   4件:
49,
51,
85,
86
 13   Bardoxolone  4件: Bardoxolone; Bardoxolone methyl; Bardoxolone methyl capsules; Bardoxolone methyl oral capsule;   D09584   -   -   7件:
66,
67,
84,
85,
86,
218,
222
 14   Bardoxolone methyl  3件: Bardoxolone methyl; Bardoxolone methyl capsules; Bardoxolone methyl oral capsule;   D09585   -   -   7件:
66,
67,
84,
85,
86,
218,
222
 15   Benzbromarone  1件: Benzbromarone;   D01056   -   -   1件:
86
 16   Beraprost  4件: Beraprost; Beraprost sodium; Beraprost sodium 314d modified release tablets; Beraprost sodium modified release;   D02720   1件: PTGIR   3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction   1件:
86
 17   Bevacizumab  4件: Bevacizumab; Bevacizumab (genitical recombination); Bevacizumab (avastin) and imatinib mesylate (gleevec); Submucosal bevacizumab;   D06409   1件: VEGFA   3件: Pathways in cancer, Renal cell carcinoma, VEGF signaling pathway   9件:
13,
34,
85,
86,
87,
89,
227,
280,
331
 18   Bisoprolol  2件: Bisoprolol; Bisoprolol fumarate;   D00634
 D02342 
 1件: ADRB1   6件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Neuroactive ligand-receptor interaction, cAMP signaling pathway, cGMP-PKG signaling pathway   3件:
67,
86,
113
 19   Bosentan  14件: Bosentan; Bosentan mylan; Bosentan (tracleer); Bosentan 125 mg; Bosentan 62.5 mg; Bosentan group; Bosentan monohydrate; Sildenafil 20mg and bosentan 62.5mg; Bosentan administration; Bosentan and sildenafil; Bosentan monohydrat; Bosentan, ambrisentan; Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan); Sildenafil singly or in association with bosentan;   D01227
 D07538 
 2件: EDNRA, EDNRB   2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction   10件:
13,
41,
47,
51,
84,
85,
86,
88,
210,
211
 20   CXA-10  3件: 150mg cxa-10; 75mg cxa-10; Cxa-10;   -   -   -   2件:
86,
222
 21   Capsaicin  4件: Capsaicin; Capsaicin challenge; Capsaicin vapor; Qutenza (8% capsaicin);   D00250   1件: TRPV1   1件: Neuroactive ligand-receptor interaction   6件:
2,
6,
19,
86,
113,
226
 22   Captopril  2件: Captopril; Spironolactone captopril carvedilol;   D00251   1件: ACE   1件: Renin-angiotensin system   2件:
17,
86
 23   Carbon monoxide  2件: Carbon monoxide; Inhaled carbon monoxide;   D09706   -   -   3件:
85,
86,
298
 24   Carvedilol  2件: Carvedilol; Spironolactone captopril carvedilol;   D00255
 D03415 
 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2   7件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   4件:
6,
57,
86,
113
 25   Cetuximab  1件: Cetuximab;   D03455   1件: EGFR   3件: ErbB signaling pathway, MAPK signaling pathway, Pathways in cancer   5件:
34,
51,
86,
89,
331
 26   Chlorhexidine  5件: Chlorhexidine; 2% chlorhexidine solution wipes; 4% chlorhexidine gluconate liquid skin cleanser; Chlorhexidine gluconate; Chlorhexidine gluconate oral rinse;   D00858
 D01345
 D03463
 D07668 
 -   -   2件:
86,
299
 27   Cicletanine  1件: Cicletanine;   D03487   -   -   1件:
86
 28   Clopidogrel  1件: Clopidogrel;   D00769
 D07729
 D10823
 D10824 
 -   -   2件:
49,
86
 29   Conivaptan  2件: Conivaptan; Spironolactone and conivaptan;   D01236
 D07748 
 2件: AVPR1A, AVPR2   2件: Neuroactive ligand-receptor interaction, Vasopressin-regulated water reabsorption   1件:
86
 30   Cyanocobalamin  0件:   D00166
 D03615
 D03616
 D03617 
 -   -   12件:
6,
13,
49,
62,
86,
96,
97,
201,
229,
254,
284,
299
 31   D-glucose  3件: 2-deoxy-2 [f-18] fluoro-2-d-glucose; D-glucose; [18f]fluoro-2-deoxy-2-d-glucose;   D00009   -   -   6件:
6,
13,
49,
86,
88,
299
 32   Dichloroacetic acid  0件:   -   -   -   1件:
86
 33   Diltiazem  3件: Diltiazem; Diltiazem hydrochloride; Dofetilide and diltiazem;   D00616
 D03830
 D07845 
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S   4件: Adrenergic signaling in cardiomyocytes, Cardiac muscle contraction, Vascular smooth muscle contraction, cAMP signaling pathway   3件:
58,
86,
130
 34   Dimethyl fumarate  4件: Dimethyl fumarate; Dimethyl fumarate (dmf); Dimethyl fumarate [dmf]; Tecifdera (dimethyl fumarate);   D03846   -   -   5件:
13,
46,
49,
51,
86
 35   Diphenhydramine  1件: Diphenhydramine;   D00300
 D00669
 D02419
 D03285
 D03360
 D03854 
 1件: HRH1   2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction   5件:
49,
51,
70,
86,
256
 36   Docusate  0件:   D00305   -   -   7件:
13,
62,
86,
96,
97,
254,
284
 37   Elafin  1件: Elafin;   -   -   -   1件:
86
 38   Epicatechin  3件: (-)-epicatechin; Epicatechin; (+)- epicatechin;   -   -   -   2件:
86,
113
 39   Epinephrine  4件: Epinephrine; Bupivacaine/epinephrine/dexamethasone; Lap tap bupivacaine/epinephrine; Us tap bupivacaine/epinephrine;   D00095
 D00996
 D02149 
 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   7件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   9件:
6,
13,
46,
86,
96,
168,
226,
231,
256
 40   Epoprostenol  7件: Act-385781a (actelion epoprostenol); Current marketed flolan (epoprostenol sodium); Epoprostenol; Epoprostenol for injection; Epoprostenol sodium; Epoprostenol-actelion; New thermo stable formulation of epoprostenol sodium;   D00106
 D01337 
 1件: PTGIR   3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction   1件:
86
 41   Esomeprazole  3件: Esomeprazole; Esomeprazole 20 mg; Nexium (esomeprazole magnesium);   D01984
 D04056
 D07917
 D09339 
 2件: ATP4A, ATP4B   3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation   6件:
6,
46,
86,
98,
298,
299
 42   Ethanol  14件: Endocannabinoid palmitoylethanolamide (pea); Palmitoylethanolamide; Treprostinil diethanolamine; Ut-15c (treprostinil diethanolamine); Ut-15c sr (treprostinil diethanolamine); Andrographis paniculata (ethanol extract); Ethanol; Ethanol (96 per cent); Ethanol 96% gel; Ethanol 98% solution; Ethanol bp; Ethanol gel; Ethanolamine; Ethanolamine oleate;   D00068
 D02798
 D04855
 D06542 
 -   -   49件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
58,
61,
63,
64,
65,
66,
81,
84,
85,
86,
88,
95,
96,
97,
113,
145,
162,
164,
222,
224,
228,
251,
279,
280,
283,
284,
285,
288,
298,
299,
300,
331
 43   Famotidine  2件: Famotidine; Famotidine 20 mg;   D00318   1件: HRH2   3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction   3件:
6,
46,
86
 44   Ferric carboxymaltose  2件: Ferric carboxymaltose; Intravenous administration of ferric carboxymaltose;   D08920   -   -   4件:
86,
96,
97,
299
 45   Fluoxetine  4件: Fluoxetine; Fluoxetine hydrochloride; Amitriptyline, fluoxetine and tramadol alone (control group); Sc recombinant growth hormone + amitriptyline, fluoxetine and tramadol (treated group);   D00326
 D00823 
 1件: SLC6A4   1件: Serotonergic synapse   6件:
13,
17,
78,
86,
179,
206
 46   Folic acid  5件: Folic acid; Folic acid, vitamin b6, vitamin b12; Folic acid or folate; Rituximab, mtx, folic acid; Methotrexate and folic acid;   D00070   -   -   11件:
6,
13,
46,
49,
62,
84,
86,
96,
97,
254,
284
 47   Fulvestrant  1件: Fulvestrant;   D01161   2件: ESR1, ESR2   3件: Breast cancer, Estrogen signaling pathway, Pathways in cancer   1件:
86
 48   Gadobenic acid  0件:   D04283
 D08018 
 -   -   3件:
13,
86,
88
 49   Glycine  4件: Glycine; Flolan tm and glycine diluent; Flolan™ and glycine diluent; Glycine buffer;   D00011   -   -   4件:
35,
86,
226,
299
 50   Hydroxyurea  1件: Hydroxyurea;   D00341   1件: RRM2   4件: Glutathione metabolism, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway   8件:
3,
13,
19,
20,
65,
85,
86,
284
 51   Ifetroban  2件: Ifetroban; Oral ifetroban;   D04500   1件: TBXA2R   2件: Neuroactive ligand-receptor interaction, Platelet activation   3件:
51,
86,
113
 52   Iloprost  21件: Iloprost; Iloprost injection, for intravenous use; Iloprost low dose; Iloprost sale di trometamolo; Iloprost therapy up to 2 ng/kg x min; Iloprost trometamol; Iloprost inhalation solution (ventavis); Aerosolized iloprost; Commercial ventavis® (iloprost); Iloprost (5 µg); Iloprost (ventavis bayq6256); Iloprost (ventavis inhaled, bayq6256); Iloprost (ventavis, bayq 6256); Iloprost (ventavis, bayq6256); Iloprost (ventavis®); Iloprost pd-15; Iloprost pd-6; Iloprost,(ventavis, bayq6256); Inhaled iloprost (ventavis, bayq6256); Ventavis (iloprost, bayq6256); Ventavis(iloprost);   D02721   1件: PTGIR   3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction   4件:
51,
84,
85,
86
 53   Imatinib  6件: Imatinib; Imatinib mesilate; Imatinib mesylate; Imatinib mesylate (gleevec); Bevacizumab (avastin) and imatinib mesylate (gleevec); Imatinib mesylate 400mg capsule;   D01441
 D08066 
 3件: ABL1, KIT, PDGFRA   3件: Chronic myeloid leukemia, MAPK signaling pathway, Pathways in cancer   11件:
13,
28,
34,
35,
46,
51,
85,
86,
87,
89,
162
 54   Ipratropium  4件: Ipratropium; Ipratropium bromide (drug); Nebulized combination ipratropium bromide with salbutamol; Nebulized ipratropium bromide;   D02212   5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5   3件: Cholinergic synapse, Neuroactive ligand-receptor interaction, cAMP signaling pathway   2件:
6,
86
 55   Iron  18件: Iron; Iron oxide; Ultra small particles of iron oxide (uspio); Ultrasmall particles of iron oxide; Iron dextran; Iron sucrose; Ambrisentan plus spironolactone; Iron supplement; Spironolactone; Spironolactone and conivaptan; Spironolactone captopril carvedilol; Injection of iron; Iron sulphate; Iron sulphate 200mg coated tablets; Iron supplement 300-600 mg/day; Iron(iii)- hydroxide dextran complex; Oral iron; Iron chelating agents;   -   -   -   7件:
13,
62,
86,
96,
97,
254,
284
 56   L-Citrulline  5件: L-citrulline; L-citrulline malate; 750 mg metformin and 7.5 g l-citrulline daily p.o.; L-citrulline and metformin & l-citrulline; Metformin and metformin & l-citrulline;   D07706   -   -   2件:
86,
113
 57   L-Threonine  2件: L-lysyl-d-prolyl-l-threonine acetate; L-threonine;   D00041   -   -   3件:
86,
96,
97
 58   Lidocaine  8件: Lidocaine; Local anesthesia (lidocaine hydrochloride); Lidocaine patch 5%; Lidocaine injection 2%; 5% lidocaine/5 mg/ml estradiol compound cream; Alkalinized lidocaine-heparin; Bladder instillation with heparin/ lidocaine; Lidocaine releasing intravesical system - liris®;   D00358
 D02086
 D08127 
 2件: SCN1A, SCN5A   2件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse   10件:
6,
13,
46,
84,
86,
97,
168,
226,
231,
256
 59   Lisuride  6件: Lisuride; Lisuride hydrogenmaleate; Lisuride transdermal system; Lisuride tts 10cm²; Lisuride tts 20cm²; Transdihydrolisuride;   D01462
 D08132 
 3件: DRD2, DRD3, DRD4   2件: Dopaminergic synapse, Neuroactive ligand-receptor interaction   2件:
6,
86
 60   Macitentan  8件: Macitentan; Act-064992 (macitentan); Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan); Fdc macitentan/tadalafil; Macitentan 10 mg; Macitentan 10 mg tablet, once daily.; Macitentan group; Opsumit (macitentan);   D10135   2件: EDNRA, EDNRB   2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction   5件:
51,
85,
86,
88,
210
 61   Medical air  4件: Medical air; Medical air (sham o2); Sham o2 (medical air); Medical air vs oxygen;   -   -   -   3件:
85,
86,
193
 62   Mercaptopurine  8件: 6 mercaptopurine; Azathioprine (aza) or 6-mercaptopurine (6-mp); Azathioprine or 6-mercaptopurine; Delayed release 6 mercaptopurine; Mercaptopurine; 6-mercaptopurine; Mercaptopurine (puri-nethol); Products containing azathioprine or 6-mercaptopurine;   D00161
 D04931 
 1件: HPRT1   1件: Purine metabolism   5件:
86,
94,
96,
97,
164
 63   Metformin  15件: Metformin; Glucophage (metformin); Metformin/cp-690,550; Metformin hydrochloride; Metformine; Metformine sandoz 850 mg filmomhulde tabletten; 750 mg metformin and 7.5 g l-citrulline daily p.o.; L-citrulline and metformin & l-citrulline; Metformin 500mg; Metformin and metformin & l-citrulline; Metformin (generic); Sitagliptin and metformin; Pioglitazone or metformin; Metformin hcl; Metformine hcl 500 pch;   D00944
 D04966 
 2件: PRKAA1, PRKAA2   3件: AMPK signaling pathway, Adipocytokine signaling pathway, Insulin signaling pathway   17件:
6,
13,
46,
49,
67,
75,
77,
81,
86,
113,
158,
206,
225,
233,
265,
285,
299
 64   Methylprednisolone  29件: Methylprednisolone; Iv methylprednisolone; Iv methylprednisolone (steroids); Megadose oral methylprednisolone; Methylprednisolone (drug); Methylprednisolone hemisuccinate; Methylprednisolone iv; Methylprednisolone sodium hemisuccinate; Methylprednisolone sodium succinate; Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Prednisone, methylprednisolone,cyclophosphamides; Methylprednisolone (or other glucocorticoid); Prednisone (and methylprednisolone); Infliximab, methylprednisolone, methotrexate; Methotrexate + methylprednisolone; Administration of rituximab and methylprednisolone; Methylprednisolone (mp); Corticosteroid treatment (methylprednisolone or prednisolone); Methylprednisolone or prednisolone; Methylprednisolone (mp) or prednisone (pred); Methylprednisolone mylan générique; Methylprednisolone pulse; Methylprednisolone(intravenously in the 1st-2nd-3rd month ); Methylprednisolone(intravenously in the 1st-3rd-5th month); Methylprednisolone bolus iv 15 mg/kg/d for 3 days.; Methylprednisolone or budesonide; Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone; Intravenous methylprednisolone; Intravenous (i.v.) methylprednisolone 1000 mg, total 9;   D00407
 D00751
 D00979
 D05000
 D05001
 D05002 
 1件: NR3C1   1件: Neuroactive ligand-receptor interaction   36件:
2,
13,
25,
26,
35,
38,
39,
40,
41,
42,
43,
45,
46,
49,
50,
51,
60,
63,
64,
65,
66,
83,
84,
86,
96,
97,
145,
164,
220,
222,
224,
271,
283,
284,
285,
296
 65   Morphine  6件: Morphine; Morphine sulphate in intrasite gel; Intraarticular morphine; Morphine hexal; Morphine sulfate; Morphine pca;   D00842
 D02271
 D08233 
 1件: OPRM1   1件: Neuroactive ligand-receptor interaction   4件:
36,
46,
70,
86
 66   Moxifloxacin  6件: Moxifloxacin; Moxifloxacin infusion; Moxifloxacina cloridrato; Avelox- moxifloxacin; Moxifloxacin 400 mg; Moxifloxacin hydrochloride;   D00874
 D08237 
 -   -   8件:
2,
6,
46,
49,
85,
86,
240,
299
 67   Nicardipine  1件: Nicardipine;   D00617
 D08270 
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S   4件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Cardiac muscle contraction, Vascular smooth muscle contraction   2件:
70,
86
 68   Nilotinib  8件: Cohort 1:nilotinib oral capsules (150mg or 300mg); Cohort 2: nilotinib oral capsules (dose to be determined from cohort 1); Nilotinib; Nilotinib 150mg oral capsule [tasigna]; Nilotinib 300mg oral capsule [tasigna]; Nilotinib 150 mg; Nilotinib hydrochloride monohydrate; Nilotinib (tasigna);   D08953   4件: ABL1, KIT, PDGFRA, PDGFRB   4件: Chronic myeloid leukemia, ErbB signaling pathway, MAPK signaling pathway, Pathways in cancer   5件:
6,
8,
34,
51,
86
 69   Nitric Oxide  11件: Nitric oxide; Inhaled nitric oxide; Inhaled nitric oxide - 30 mcg/kg ibw/hr; Inhaled nitric oxide 5,10,15 mcg/kg ibw/hr; Inhaled nitric oxide 75 mcg/kg ibw/hr; Inhaled nitric oxide & inopulse delivery; Nitric oxide for inhalation; Nitric oxide generated by the geno nitrosyl delivery system; Nitric oxide plus oxygen; Nitric oxide supplement; Nitric oxide 160 ppm;   D00074   -   -   7件:
46,
85,
86,
98,
251,
294,
299
 70   Nitrite  9件: 120 mg sodium nitrite inhalation solution; 15 mg sodium nitrite inhalation solution; 25% mtd sodium nitrite inhalation solution; 45 mg sodium nitrite inhalation solution; 90 mg sodium nitrite inhalation solution; Air001 (sodium nitrite inhalation solution); Nitrite; Sodium nitrite; Sodium nitrite inhalation solution;   -   -   -   2件:
86,
299
 71   Olaparib  1件: Olaparib;   D09730   3件: PARP1, PARP2, PARP3   3件: Apoptosis, Base excision repair, Necroptosis   1件:
86
 72   Oxygen  10件: Oxygen; Oxygen 40 %; Nitric oxide plus oxygen; Oxygen supplementation; Continuous oxygen; Medical air vs oxygen; Maternal hyperoxygenation; Medical grade oxygen; Perfluorinated gas/oxygen mixture; Helium / oxygen mixed gas inhalation therapy;   D00003   -   -   18件:
5,
6,
17,
46,
49,
70,
84,
85,
86,
88,
90,
96,
97,
193,
211,
226,
299,
330
 73   PF-00489791  1件: Pf-00489791;   -   -   -   1件:
86
 74   Pioglitazone  6件: Pioglitazone; Pioglitazone and tretinoin; Tretinoin and pioglitazone hcl; Actos (pioglitazone); Pioglitazone 15 mg; Pioglitazone or metformin;   D00945
 D08378 
 1件: PPARG   2件: AMPK signaling pathway, PPAR signaling pathway   17件:
2,
6,
13,
15,
20,
46,
49,
65,
67,
78,
81,
86,
96,
229,
265,
298,
299
 75   Prasterone  2件: Prasterone; Prasterone (gl701);   D08409   2件: ESR1, ESR2   1件: Estrogen signaling pathway   6件:
49,
53,
83,
86,
96,
113
 76   Prednisone  59件: Prednisone; Prednisone - azathioprine; Prednisone alone; Granulocyte-colony stimulating factor (g-csf) and prednisone; Prednisone/prednisolone; Prednisone acetate; Prednisone, cyclophosphamide; Over encapsulated prednisone; Prednisone and ustekinumab treatment; Prednisone capsules; Prednisone tablets usp, 1 mg; Prednisone tablets usp, 2.5 mg; Prednisone tablets usp, 5 mg; Prednisone tablets, usp; Prednisone therapy and pharmacokinetic; Prednisone treatment; Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Prednisone, methylprednisolone,cyclophosphamides; Prednisone (and methylprednisolone); 0 mg prednisone; 5 mg prednisone; Methylprednisone; Prednisone 15 mg; Prednisone 5 mg; Prednisone 7.5 mg; Rayos (delayed-release prednisone); Corticosteroids (prednisone or prednisolone); Cyclophosphamide-prednisone-azathioprine; Oral prednisone 5mg; Prednisone discontinuation; Chinese herb prescription granule plus prednisone; Enalapril valsartan methylprednisone; Hormone (prednisone); Leflunomide 20 mg+prednisone 0.5mg/kg/d; Methylprednisolone (mp) or prednisone (pred); Mycophenolate mofetil plus lower dose of prednisone; Prednisone + inhibace/cozaar; Prednisone and cyclophosphamide; Prednisone arrow 20mg; Prednisone arrow 5 mg; Prednisone in full dose; Prednisone or prednisolone; Prednisone plus cyclophosphamide; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Glucocorticoid (prednisone or prednisolone); Hydroxychloroquine + prednisone; Azathioprine/prednisone; 5-asa, prednisone, azathioprine or remicade; 5-aminosalicylic acid(5-asa) and/or prednisone; Treatment systemic therapy (prednisone); Treatment with systemic therapy (prednisone); Prednisone 0,5 mg/kg orally on alternate days; Prednisone, fk506, mmf; Tacrolimus combined with prednisone; Prednisone acetate tablets; Oral prednisone; Sotatercept with prednisone boost; Prednisone and mycophenolate mofetil; Thalidomide, cyclophosphamide and prednisone;   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   44件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
61,
63,
64,
65,
66,
81,
84,
85,
86,
95,
96,
97,
113,
145,
162,
164,
222,
224,
228,
251,
283,
284,
285,
288,
299,
300,
331
 77   Ralinepag  1件: Ralinepag;   D10725   1件: PTGIR   2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction   1件:
86
 78   Ranolazine  7件: Ranolazine; Ranolazine 1000 mg; Ranolazine 500 mg; Ranolazine 1000 mg pr tablets; Ranolazine 500 mg pr tablets; Ranolazine 750 mg pr tablets; Ranolazine pr (prolonged-release) 500 mg 1 tablet bis in die and 750 mg 1 tablet bis in die;   D05700
 D05701 
 -   -   6件:
2,
58,
86,
113,
114,
130
 79   Rifampicin  1件: Rifampicin;   D00211   -   -   7件:
6,
13,
17,
46,
84,
86,
299
 80   Riociguat  12件: Riociguat; Riociguat (adempas, bay63-2521); Riociguat coated tablet 0.5 mg; Riociguat coated tablet 1.0 mg; Riociguat coated tablet 1.5 mg; Riociguat coated tablet 2.0 mg; Riociguat coated tablet 2.5 mg; Adempas (riociguat, bay63-2521); Riociguat (bay63-2521); Riociguat granules 0.3% for oral application; Riociguat oral product; Riociguat pill;   D09572   3件: GUCY1A1, GUCY1A2, GUCY1B1   2件: Platelet activation, Vascular smooth muscle contraction   6件:
51,
84,
86,
88,
225,
299
 81   Ritonavir  9件: Ritonavir; Saquinavir and ritonavir; Lopinavir / ritonavir; Atazanavir (atv) + ritonavir (rtv), continuation of backbone 2 nucleoside reverse transcriptase inhibitor (nrtis); Atazanavir/ritonavir; Lopinavir/ritonavir; Lopinavir/ritonavir + nevirapine; Lopinavir/ritonavir + zidovudine + lamivudine; Ritonavir (norvir);   D00427   -   -   5件:
2,
86,
130,
265,
299
 82   Rituximab  52件: Rituximab; Rituximab (rituxan); Mabthera (rituximab); Mabthera or biosimilar rituximab product; Rituximab infusion; Rituximab it; Rituximab iv; Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine; Rituximab (mabthera® or rituxan®).; Rituximab and cyclophosphamide iv; Rituximab (arm a); Rituximab (arm b); Abatacept, rituximab or tocilizumab; Abp 798 - biosimilar to rituximab; Gp2013 - a proposed biosimilar rituximab; Idec-c2b8 (rituximab); Mabthera® (rituximab); Originator rituximab - rituxan ® or mabthera ®; Rituxan (inn: rituximab), brand name in the united states; Rituxan® (rituximab); Rituximab - mabthera; Rituximab [mabthera/rituxan]; Rituximab [mabthera]; Rituximab mabthera; Rituximab, mtx, folic acid; Rituximab, observational study amon patients with active ra; Rituximab-eu+ rituximab-pfizer x 2 courses; Rituximab-pfizer (pf-05280586) x 3 courses; Rituximab-us + rituximab-pfizer x 2 courses; Sait101 (proposed rituximab biosimilar); Individualized dose of rituximab; Rituxan (rituximab); Standard dose of rituximab; Administration of rituximab and methylprednisolone; Rituximab (anti-cd20); Alemtuzumab and rituximab; Bendamustine, rituximab; Mabthera or biosimilar rituximab; Rituximab (mabthera®); Alemtuzumab, rituximab; Dexamethasone and rituximab; Rhtpo in combination with rituximab; Immunosuppressive treatment (eg, rituximab); Rituximab (rtx) and azathioprine (aza); Intravenous rituximab; Combined plasma exchange (pex), rituximab, and corticosteroids; The standard steroid treatment, plasma exchange and rituximab; Rituximab 1g iv; Rituximab combined with omalizumab; Experimental (non immunosuppressive symptomatic treatment (nist) and rituximab); Rituximab/ mabthera; Rituximab or rituximab hyaluronidase human;   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   42件:
11,
13,
14,
17,
35,
36,
43,
44,
45,
46,
49,
50,
51,
52,
53,
56,
60,
61,
63,
64,
65,
66,
83,
84,
85,
86,
93,
94,
96,
97,
162,
222,
223,
229,
256,
271,
283,
284,
285,
288,
300,
331
 83   Salbutamol  5件: Salbutamol; Salbutamol 4mg tablet; R-salbutamol; R-salbutamol sulphate; Nebulized combination ipratropium bromide with salbutamol;   D02147   1件: ADRB2   3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, cAMP signaling pathway   13件:
3,
11,
12,
13,
49,
85,
86,
89,
113,
228,
231,
256,
299
 84   Sapropterin  11件: Sapropterin; Sapropterin dihydrochloride (6r-bh4); Kuvan® (sapropterin dihydrochloride); Sapropterin (kuvan); Sapropterin dihydrochloride; Sapropterin dihydrochloride, 6r-bh4, tetrahydrobiopterin; Sapropterin dihydrocholoride; Sapropterin hydrochloride; Sapropterin, sapropterin dihydrochloride; Sapropterin, sapropterin hydrochloride; Sapropterindihydrochloride;   D08505   -   -   3件:
86,
124,
240
 85   Saquinavir  2件: Saquinavir; Saquinavir and ritonavir;   D00429
 D01160 
 -   -   2件:
86,
265
 86   Selexipag  4件: Selexipag; I.v. selexipag; Oral selexipag (uptravi); Selexipag (uptravi);   D09994   1件: PTGIR   3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction   5件:
51,
70,
84,
86,
88
 87   Selonsertib  1件: Selonsertib;   D10988   1件: MAP3K5   3件: Apoptosis, MAPK signaling pathway, Non-alcoholic fatty liver disease (NAFLD)   1件:
86
 88   Serine  4件: L-serine; Serine; D-serine; D-serine (~2g/day);   D00016   -   -   3件:
2,
6,
86
 89   Sildenafil  25件: Sildenafil; 5% sildenafil cream; Sildenafil 20mg; Sildenafil 20mg and bosentan 62.5mg; Sildenafil citrate; Sildenafil therapy; Sildenafil (50 mg); Sildenafil and losartan; 20 mg sildenafil citrate by mouth; Access program - sildenafil citrate, viagra, revatio; Bosentan and sildenafil; Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan); Oral sildenafil; Sildenafil (as citrate); Sildenafil (revatio); Sildenafil (revatio) 20 mg tid; Sildenafil citrate (uk-92,480); Sildenafil singly or in association with bosentan; Sitaxsentan and sildenafil; Sodium tanshinone iia sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth; Tadalafil and sildenafil; Sildenafil 20 mg tablets; Acute (1 hour) sildenafil; Sildenafil 40mg oral capsule; Sub-chronic (4 weeks) sildenafil;   D02229
 D08514 
 1件: PDE5A   1件: cGMP-PKG signaling pathway   16件:
6,
46,
50,
51,
85,
86,
96,
113,
210,
211,
212,
225,
226,
278,
294,
299
 90   Simvastatin  16件: Simvastatin; Simvastatine; Encapsulated simvastatin tablets; Simvastatin 40 mg film-coated tablets; Simvastatin alternova; Simvastatina; Simvastatina sandoz 40 mg comprimidos recubiertos con película efg; Simvastatine sandoz 40 mg filmomhulde tabletten; Simvastatine sandoz 40mg deelbare filmomhulde tabletten; Simvastatin 20mg/5ml oral suspension; Ezetimibe+simvastatin drug combination; Simvastatin 40mg; Simvastatin-ratiopharm; Simvastatin-ratiopharm®; Simvastatin treatment for 28 days; Simvastatin susp.;   D00434   1件: HMGCR   1件: Terpenoid backbone biosynthesis   19件:
6,
13,
15,
34,
46,
49,
51,
66,
79,
86,
89,
94,
158,
162,
195,
265,
298,
299,
310
 91   Sirolimus  16件: Sirolimus; Temsirolimus; Temsirolimus tablets; Sirolimus 2 mg; Skincerity plus sirolimus/rapamycin; Skinercity plus sirolimus/rapamycin; Sirolimus (formerly known as rapamycin); Sirolimus 2%; Sirolimus, 2%; Rapamycin, sirolimus; Sirolimus and hydroxychloroquine; Sirolimus 0.2%; Sirolimus 0.4%; Sirolimus 0,1% crème; Sirolimus oral liquid product 1mg/ml; Topical 0.1% sirolimus;   D00753   1件: MTOR   2件: Pathways in cancer, mTOR signaling pathway   36件:
2,
13,
15,
17,
34,
35,
36,
46,
49,
51,
60,
61,
62,
63,
65,
66,
67,
85,
86,
89,
96,
98,
137,
157,
158,
192,
222,
256,
277,
278,
279,
280,
281,
283,
285,
331
 92   Sitaxentan  2件: Sitaxentan; Sitaxentan sodium;   D07171   1件: EDNRA   2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction   1件:
86
 93   Sodium chloride  14件: 0.9% sodium chloride; 0.9% sodium chloride (normal saline); Sodium chloride; Sodium chloride solution; Isotonic sodium chloride solution; 0.9% sodium chloride injection; Physiological serum (sodium chloride); Sodium chloride solvent; Sodium chloride solution 0.9%; 0.9% w/v sodium chloride solution; Sodium chloride (7%); Sodium chloride 0,9%; Sodium chloride 6%; Sodium pyruvate in 0.9% sodium chloride solution;   D02056   -   -   19件:
6,
11,
13,
14,
17,
34,
46,
51,
53,
67,
78,
86,
97,
168,
193,
227,
228,
288,
299
 94   Sorafenib  3件: Nexavar (bay 43-9006) (sorafenib); Sorafenib; Sorafenib (as tosylate);   D06272
 D08524 
 8件: BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET   7件: ErbB signaling pathway, Hepatocellular carcinoma, MAPK signaling pathway, Pathways in cancer, Renal cell carcinoma, Thyroid cancer, VEGF signaling pathway   2件:
34,
86
 95   Sotatercept  2件: Sotatercept; Sotatercept with prednisone boost;   D09670   1件: ACVR2A   2件: Cytokine-cytokine receptor interaction, TGF-beta signaling pathway   2件:
86,
284
 96   Spironolactone  4件: Spironolactone; Ambrisentan plus spironolactone; Spironolactone and conivaptan; Spironolactone captopril carvedilol;   D00443   1件: NR3C2   1件: Aldosterone-regulated sodium reabsorption   6件:
58,
67,
86,
113,
218,
225
 97   Sulfate ion  0件:   -   -   -   22件:
2,
6,
11,
13,
26,
34,
36,
46,
49,
60,
61,
64,
66,
79,
86,
96,
222,
226,
265,
296,
297,
299
 98   Tacrolimus  13件: Tacrolimus; Tacrolimus capsule; Interferon beta-1b and tacrolimus; Non-mtx dmards (e.g. sulfasalazine, leflunomide, bucillamine, tacrolimus, or mizoribin); Tacrolimus (prograf®); Tacrolimus with methotrexate; Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf; Lcp-tacro (tacrolimus); Rectal tacrolimus; Tacrolimus capsules; Tacrolimus combined with prednisone; Tacrolimus and mmf; Tacrolimus prolonged-release hard capsules;   D00107
 D08556 
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   30件:
2,
11,
13,
36,
46,
49,
50,
51,
53,
60,
61,
62,
65,
66,
85,
86,
95,
96,
97,
113,
151,
158,
164,
222,
224,
226,
228,
283,
284,
299
 99   Tadalafil  11件: Tadalafil; Tadalafil and ambrisentan upfront combination therapy; Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan); Fdc macitentan/tadalafil; Tadalafil 20 mg film-coated tablets; Tadalafil 40 mg; Tadalafil oral suspension; Tadalafil, placebo; Tadalafil- tablet or oral suspension; Tadalafil 20 mg; Tadalafil and sildenafil;   D02008   1件: PDE5A   1件: Purine metabolism   6件:
6,
51,
75,
84,
86,
113
 100   Tamoxifen  3件: Tamoxifen; Tamoxifen 40 mg daily for one year; Tamoxifen citrate;   D00966
 D08559 
 2件: ESR1, ESR2   3件: Breast cancer, Estrogen signaling pathway, Pathways in cancer   4件:
2,
86,
113,
227
 101   Terguride  3件: Terguride; Terguride hydrogenmaleate; Terguride 0.5 mg tablet;   D01348   2件: DRD2, PRL   3件: Dopaminergic synapse, Neuroactive ligand-receptor interaction, Prolactin signaling pathway   2件:
51,
86
 102   Tezosentan  1件: Tezosentan;   -   -   -   1件:
86
 103   Thrombin  1件: Thrombin;   D00090   -   -   2件:
86,
88
 104   Tocilizumab  26件: Tocilizumab; Tocilizumab injection; Tocilizumab (mra-sc); Corticoids+ tocilizumab 8mg/kg/4 weeks; Tocilizumab + glucocorticoids (gcs); Tocilizumab sc; Tocilizumab treatment; Abatacept, rituximab or tocilizumab; Decrease tocilizumab, abatacept; Intra-articular tocilizumab; Mra (tocilizumab); Mra(tocilizumab); Subcutaneous tocilizumab; Tocilizumab (actemra®); Tocilizumab + methotrexate(mtx); Tocilizumab 162 mg; Tocilizumab 162mg/0.9ml jeringa sc; Tocilizumab [roactemra/actemra]; Tocilizumab [roactemra]; Tocilizumab prefilled syringe; Tocilizumab+methotrexate(mtx); Tocilizumab, abatacept; Tocilizumabum; Tocilizumab sc 162 mg/0.9 ml prefilled syringe with safety device (pfs); Inn-tocilizumab; Tocilizumab infusion roacemtra (eu);   D02596   1件: IL6R   3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway   16件:
2,
13,
40,
41,
43,
46,
50,
51,
53,
54,
55,
86,
107,
266,
271,
331
 105   Treprostinil  32件: Iontophoresis of treprostinil; Oral treprostinil; Treprostinil; Treprostinil diethanolamine; Inhaled treprostinil; Treprostinil sodium for inhalation; Eutonic treprostinil solution; Hypotonictreprostinil solution; Inhaled dry powder treprostinil (liq861); Intravenous treprostinil; Intravenous/subcutaneous treprostinil; Liq861 inhaled treprostinil; Oral treprostinil (ut-15c) sustained release tablets; Parenteral remodulin (treprostinil) injection; Rapid dose titration group of subcutaneous treprostinil; Remodulin (treprostinil sodium); Remodulin® (treprostinil) 1 mg/ml solution for infusion; Remodulin® (treprostinil) 10 mg/ml solution for infusion; Remodulin® (treprostinil) 2.5 mg/ml solution for infusion; Remodulin® (treprostinil) 5 mg/ml solution for infusion; Slow dose titration group of subcutaneous treprostinil; Subcutaneous treprostinil; Treprostinil diolamine; Treprostinil inhalation powder; Treprostinil inhalations; Treprostinil injectable product; Treprostinil sodium; Treprostinil sodium solution for inhalation; Treprostinil sodium, ut-15; Treprostinil, ut-15, lrx-15, 15au81, bw a15au, u-62, 840; Ut-15c (treprostinil diethanolamine); Ut-15c sr (treprostinil diethanolamine);   D06213   1件: PTGIR   3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction   5件:
51,
84,
85,
86,
88
 106   Trimetazidine  3件: Trimetazidine; Trimetazidine dihydrochloride; Trimetazidine dihydrochloride 20mg;   D01606
 D08642 
 -   -   2件:
58,
86
 107   Tyrosine  2件: L-tyrosine; Tyrosine;   D00022   -   -   3件:
6,
86,
111
 108   Ubenimex  1件: Ubenimex;   D00087   -   -   1件:
86
 109   Ubidecarenone  0件:   D01065   -   -   12件:
2,
5,
6,
8,
10,
46,
57,
86,
113,
193,
214,
215
 110   Udenafil  1件: Udenafil;   D10027   1件: PDE5A   1件: cGMP-PKG signaling pathway   1件:
86
 111   Vardenafil  4件: Vardenafil; Vardenafil (hidrocloride); Vardenafilo; Vardenafilo hidrocloruro;   D02731
 D03260
 D08668 
 1件: PDE5A   1件: cGMP-PKG signaling pathway   3件:
13,
86,
299
 112   Zamicastat  1件: Zamicastat;   -   -   -   1件:
86
 113   Zinc acetate  3件: Zinc acetate; Zinc acetate dihydrate; Zinc acetate (20mg/d);   D06408   -   -   7件:
49,
51,
70,
86,
171,
256,
299

先頭へ